Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.04. | EXICURE, INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
06.02. | Exicure and Bluejay sign hepatitis treatment development deal | 4 | Pharmaceutical Business Review | ||
05.02. | EXICURE, INC. - 8-K, Current Report | 5 | SEC Filings | ||
16.01. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
08.12.23 | Why Is Exicure (XCUR) Stock Up 57% Today? | 10 | InvestorPlace | ||
28.11.23 | EXICURE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
14.11.23 | EXICURE, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
11.08.23 | Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update | 477 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against... ► Artikel lesen | |
14.07.23 | Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update | 671 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 5,345 | -2,11 % | Aurora Cannabis Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
ABBVIE | 154,38 | +0,32 % | Dividendenbekanntmachungen (12.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,55 USD 0,5127 EUR ABBVIE INC US00287Y1091 1,55 USD 1,4449 EUR ABBVIE INC CDR CA00288K1084 0... ► Artikel lesen | |
CANOPY GROWTH | 6,040 | -0,66 % | Tilray-Aktie schockt Anleger: Darum sind auch Cannabis-Werte wie Canopy Growth jetzt unter Druck | Politischer Rückenwind und eine Teil-Legalisierung in Deutschland halfen Cannabis-Aktien zuletzt. Die neuen Zahlen von Tilray haben das Momentum der Branche aber vorerst zerstört. Wie geht es weiter?... ► Artikel lesen | |
TILRAY BRANDS | 1,609 | +0,06 % | No Cannabis Tax Relief In Canada, Tilray CEO Says This 'Hinders Our Ability To Compete With The Illicit Market' | ||
TEVA | 12,250 | -1,21 % | Teva Pharmaceutical Industries Limited: Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab) | SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be... ► Artikel lesen | |
INNOCAN PHARMA | 0,197 | -2,24 % | 3-2-1-Zündung! CEO deutet Mega News auf "X" an?! | ||
TAAT GLOBAL ALTERNATIVES | 0,163 | -5,52 % | TAAT Global Alternatives Inc (2): TAAT to issue update on FY 2023 results filing April 26 | ||
CRONOS GROUP | 2,222 | -2,20 % | Cronos Group Inc. - 8-K, Current Report | ||
SYNBIOTIC | 9,540 | +1,92 % | "Wollen die erfolgreichste paneuropäische Hanf- und Cannabis-Holding aufbauen" - Interview mit Daniel Kruse, SynBiotic SE | SYNBIOTIC ist eine börsennotierte Unternehmensgruppe (ISIN: DE000A3E5A59), die sich auf die umfassende Nutzung des Potenzials der Hanf- und Cannabispflanze spezialisiert hat. Zum weiteren Unternehmenswachstum... ► Artikel lesen | |
VIATRIS | 10,350 | -0,48 % | Viatris Inc.: Viatris Appoints Corinne Le Goff as Chief Commercial Officer | PITTSBURGH, April 15, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial Officer and... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 20,990 | +6,79 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients... ► Artikel lesen | |
BAUSCH HEALTH | 8,049 | -0,87 % | Bausch Health Companies Inc.: Bausch Health to Announce First-Quarter 2024 Results on May 2 | LAVAL, QC / ACCESSWIRE / April 11, 2024 / Bausch Health Companies Inc. (NYSE:NHC)(TSX:BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024. Bausch Health will host a conference... ► Artikel lesen | |
ORGANIGRAM | 1,694 | -1,51 % | 50 - 200 % * X mit Cannabis Aktien? Aurora, Tilray, Organigram, Planet 13, High Tide, Village Farms | Sind Sie daran interessiert, in Cannabis-Aktien zu investieren, und fragen Sie sich nach den möglichen Renditen? In diesem Kommentar besprechen wir die Möglichkeit, mit Unternehmen wie Aurora Cannabis... ► Artikel lesen | |
CRESCO LABS | 2,012 | -1,18 % | It's A Matter Of When: Cresco Labs CEO Forecasts Cannabis Rescheduling And Industry Reform | ||
IONIS PHARMACEUTICALS | 38,760 | +1,10 % | Ionis Pharmaceuticals, Inc.: Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome | - Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction in acute pancreatitis events -
-... ► Artikel lesen |